시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 3D 심장 매핑 시스템 시장 보고서(2025년)
3D Cardiac Mapping System Global Market Report 2025
상품코드 : 1825590
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

3D 심장 매핑 시스템 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2029년에는 CAGR 9.5%로 27억 2,000만 달러로 성장합니다. 예측 기간 중의 성장 배경에는 급속한 도시화, 조기 및 정확한 진단에 대한 수요 증가, 의료 서비스 프로바이더의 인식 제고, 맞춤형 의료에 대한 중요성 증가, 실시간 고해상도 심장 매핑에 대한 수요 증가 등이 있습니다. 예측 기간의 주요 동향으로는 인공지능과 머신러닝의 통합, '환자 중심 의료'에 대한 집중, 복잡한 부정맥 관리 분야에서의 적용 확대, 실시간 3D 시각화 및 매핑 개선, 전극 밀도를 높인 카테터 디자인 강화 등이 있습니다.

향후 5년간 9.5%의 성장률 전망은 지난번 예측보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 일본과 독일에서 수입되는 고정밀 전기생리학적 부품과 센서 어레이에 대한 접근을 제한하고, 첨단 심장 수술을 지연시키거나 병원 운영 비용을 증가시킬 수 있으므로 미국에 심각한 도전이 될 수 있습니다. 또한 상호 관세와 무역 긴장의 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

심혈관 질환의 유병률 증가는 3D 심장 매핑 시스템 시장의 성장을 가속할 것으로 예측됩니다. 심혈관 질환 증가는 고령화, 불건강한 생활습관, 비만, 당뇨병, 고혈압, 스트레스, 유전, 환경오염, 의료 접근성 제한, 사회경제적 격차 등의 요인에 의해 영향을 받습니다. 3D 심장 매핑 시스템은 심장 활동의 상세한 실시간 지도를 제공하여 부정맥 및 기타 심장 관련 문제의 정확한 진단 및 치료를 지원함으로써 심혈관 질환 환자를 돕습니다. 예를 들어 2024년 1월 영국에 기반을 둔 심혈관 연구 자선단체인 British Heart Foundation은 남성 400만 명, 여성 360만 명을 포함한 영국내 약 760만 명이 심장 및 순환기 질환을 앓고 있다고 보고했습니다. 이들 질병은 영국 전체 사망자의 약 27%를 차지하며, 연간 17만 명 이상, 매일 약 480명이 사망하고 있습니다. 그 결과, 심혈관 질환의 유병률 증가가 3D 심장 매핑 시스템 시장의 성장에 박차를 가하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장의 거시경제 시나리오 : 금리·인플레이션·지정학·무역 전쟁·관세·Covid와 회복이 시장에 미치는 영향을 포함한다

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계 시장 : 경쟁 벤치마킹·대시보드

제33장 주요 기업인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력의 높은 국가·부문과 전략

제36장 부록

KSA
영문 목차

영문목차

A three-dimensional (3D) cardiac mapping system is a medical device that uses specialized catheters with electrodes inserted into the heart chambers. This system is employed in electrophysiology procedures to generate detailed, three-dimensional maps of the heart's electrical activity.

Key components of 3D cardiac mapping systems include mapping systems, mapping catheters, mapping accessories, and mapping software. Mapping systems create precise spatial representations of cardiac anatomy and electrical activity to aid in the diagnosis and treatment of cardiac arrhythmias. These systems utilize technologies such as electroanatomical mapping, magnetic resonance imaging (MRI) mapping, computed tomography (CT) mapping, and ultrasound mapping. They are used to address conditions such as atrial fibrillation, ventricular tachycardia, atrial flutter, and supraventricular tachycardia. The systems are employed in various settings, including hospitals, cardiac catheterization laboratories, ambulatory surgical centers, and academic and research institutes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The 3D cardiac mapping system market research report is one of a series of new reports from The Business Research Company that provides 3D cardiac mapping system market statistics, including 3D cardiac mapping system industry global market size, regional shares, competitors with a 3D cardiac mapping system market share, detailed 3D cardiac mapping system market segments, market trends and opportunities, and any further data you may need to thrive in the 3D cardiac mapping system industry. This 3D cardiac mapping system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 3D cardiac mapping system market size has grown strongly in recent years. It will grow from $1.73 billion in 2024 to $1.89 billion in 2025 at a compound annual growth rate (CAGR) of 9.5%. The growth in the historic period can be attributed to the prevalence of atrial fibrillation, rising obesity rates, the growing adoption of sedentary lifestyles, positive economic indicators, and rising disposable incomes.

The 3D cardiac mapping system market size is expected to see strong growth in the next few years. It will grow to $2.72 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to rapid urbanization, increasing demand for early and accurate diagnosis, rising awareness among healthcare providers, growing emphasis on personalized medicine, and rising demand for real-time, high-resolution cardiac mapping. Major trends in the forecast period include the integration of artificial intelligence and machine learning, a focus on patient-centric care, the expansion of applications in complex arrhythmia management, improved real-time 3D visualization and mapping, and enhanced catheter designs with increased electrode density.

The forecast of 9.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for the U.S. by restricting access to high-precision electrophysiology components and sensor arrays imported from Japan and Germany, potentially delaying advanced cardiac procedures and increasing hospital operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of cardiovascular diseases is anticipated to drive the growth of the 3D cardiac mapping system market. The rise in cardiovascular diseases is influenced by factors such as aging, unhealthy lifestyles, obesity, diabetes, high blood pressure, stress, genetics, environmental pollution, limited access to healthcare, and socioeconomic disparities. A 3D Cardiac Mapping System aids patients with cardiovascular conditions by providing detailed, real-time maps of heart activity, which supports precise diagnosis and treatment of arrhythmias and other heart-related issues. For example, in January 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, including 4 million men and 3.6 million women. These diseases account for around 27% of all deaths in the UK, leading to over 170,000 deaths annually, or about 480 deaths each day. Consequently, the increasing prevalence of cardiovascular diseases is fueling the growth of the 3D cardiac mapping system market.

Leading companies in the 3D cardiac mapping system market are concentrating on developing advanced solutions, such as systems equipped with machine learning capabilities, to enhance diagnostic accuracy and improve treatment outcomes. 3D cardiac mapping systems with machine learning integrate three-dimensional mapping of the heart's electrical activity with artificial intelligence algorithms. For instance, in May 2024, Biosense Webster Inc., a US-based company specializing in cardiac arrhythmia treatment solutions, launched the CARTO 3 System Version 8. This system features machine learning through modules such as the CARTO ELEVATE Module and the CARTOSOUND FAM Module, designed to boost efficiency, consistency, and precision during catheter ablation procedures performed by electrophysiologists. The CARTO 3 system enhances signal analysis, refines substrate characterization, and integrates ultrasound technology for a more effective procedure experience.

In August 2022, Medtronic plc, an Ireland-based medical equipment manufacturer, acquired Affera Inc. for $0.925 billion. This acquisition enables Medtronic to provide a fully integrated diagnostic and therapeutic system for treating various cardiac arrhythmias, including atrial fibrillation. Affera Inc., a US-based medical technology company, offers the Affera Prism-1 cardiac mapping and navigation platform.

Major companies operating in the 3D cardiac mapping system market are Hitachi Ltd., Abbott Laboratories, Siemens Healthineers, Koninklijke Philips N.V, GE HealthCare Technologies Inc, Boston Scientific Corporation, Medtronic PLC, Biotronik Inc, Microport Scientific Inc., Biosense Webster Inc., BioSig Technologies Inc., Heartflow Inc., Stereotaxis Inc., Kardium Inc., Acutus Medical Inc., Volta Medical Inc., Catheter Precision Inc., Osypka Medical Inc., Sichuan Jinjiang Electronic Science and Technology Co Ltd, APN Health LLC, CoreMap Inc.

North America was the largest region in the 3D cardiac mapping system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the 3D cardiac mapping system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the 3D cardiac mapping system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 3D cardiac mapping system market consists of revenues earned by entities by providing services such as arrhythmia detection, ablation guidance, cardiac anatomy visualization, integration with imaging modalities, real-time monitoring, preoperative planning, and postoperative assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The 3D cardiac mapping system market also includes sales of cardiac ablation devices, electrophysiology recording systems, fluoroscopy imaging systems, real-time navigation systems, radiofrequency generators, and cryoablation catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

3D Cardiac Mapping System Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 3d cardiac mapping system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for 3d cardiac mapping system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The 3d cardiac mapping system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. 3D Cardiac Mapping System Market Characteristics

3. 3D Cardiac Mapping System Market Trends And Strategies

4. 3D Cardiac Mapping System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global 3D Cardiac Mapping System Growth Analysis And Strategic Analysis Framework

6. 3D Cardiac Mapping System Market Segmentation

7. 3D Cardiac Mapping System Market Regional And Country Analysis

8. Asia-Pacific 3D Cardiac Mapping System Market

9. China 3D Cardiac Mapping System Market

10. India 3D Cardiac Mapping System Market

11. Japan 3D Cardiac Mapping System Market

12. Australia 3D Cardiac Mapping System Market

13. Indonesia 3D Cardiac Mapping System Market

14. South Korea 3D Cardiac Mapping System Market

15. Western Europe 3D Cardiac Mapping System Market

16. UK 3D Cardiac Mapping System Market

17. Germany 3D Cardiac Mapping System Market

18. France 3D Cardiac Mapping System Market

19. Italy 3D Cardiac Mapping System Market

20. Spain 3D Cardiac Mapping System Market

21. Eastern Europe 3D Cardiac Mapping System Market

22. Russia 3D Cardiac Mapping System Market

23. North America 3D Cardiac Mapping System Market

24. USA 3D Cardiac Mapping System Market

25. Canada 3D Cardiac Mapping System Market

26. South America 3D Cardiac Mapping System Market

27. Brazil 3D Cardiac Mapping System Market

28. Middle East 3D Cardiac Mapping System Market

29. Africa 3D Cardiac Mapping System Market

30. 3D Cardiac Mapping System Market Competitive Landscape And Company Profiles

31. 3D Cardiac Mapping System Market Other Major And Innovative Companies

32. Global 3D Cardiac Mapping System Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 3D Cardiac Mapping System Market

34. Recent Developments In The 3D Cardiac Mapping System Market

35. 3D Cardiac Mapping System Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기